Cervical cancer (cervical carcinoma) – What is it?
Cervical cancer, medically known as cervical carcinoma, is a malignant tumour of the cervix (cervix uteri). The cervix forms the lower part of the womb and connects the womb to the vagina. In most cases, cervical cancer is caused by a long-standing infection with certain human papillomaviruses (HPV). So-called high-risk HPV types, in particular, can cause cellular changes in the cervix over a prolonged period. Over several years, these changes can develop into precancerous lesions and eventually into a tumour. This development often occurs gradually. Initially, there are usually no symptoms; instead, cellular changes occur, known as cervical intraepithelial neoplasia (CIN) or dysplasia. These precancerous changes can be detected and treated during screening before they develop into cervical cancer. Not every HPV infection leads to cancer. In most cases, the immune system clears the virus on its own. A key factor in the development of cancer is, above all, a long-standing infection with high-risk HPV types. 
Where does cervical cancer develop?
Cervical cancer usually develops in what is known as the transformation zone of the cervix. This is a transitional area where two different types of mucosal cells meet: the squamous epithelium of the outer surface of the cervix and the glandular epithelium of the cervical canal. This area is particularly susceptible to cellular changes that can result from a long-standing infection with high-risk HPV types. Over a period of several years, these changes can develop into precancerous lesions and, subsequently, cervical cancer. Doctors primarily distinguish between two common forms of cervical cancer:
- Squamous cell carcinoma: This type of tumour arises from the squamous epithelial cells on the surface of the cervix. Accounting for around 70 to 80 per cent of cases, it is the most common form of cervical cancer.
- Adenocarcinoma: This type of tumour arises from the glandular cells of the cervical canal. It accounts for around 10 to 20 per cent of cases.
Other types of tumour are less common, such as mixed forms comprising squamous cell carcinoma and adenocarcinoma, or neuroendocrine tumours.
Prevalence of cervical cancer
According to Statistics Austria, 439 women were newly diagnosed with cervical cancer in Austria in 2022. 129 women died as a result of the disease. At the end of 2022, 9,022 women were living with a diagnosis of cervical cancer. The disease is most commonly diagnosed in women aged between 35 and 64.
What causes cervical cancer?
The main cause of cervical cancer is a persistent infection with certain types of human papillomavirus (HPV). Almost all cases of cervical cancer are linked to infection with so-called high-risk HPV types. However, HPV infection is common and, in many cases, clears up on its own. It is only when certain types of the virus remain in the body for a prolonged period and cause cellular changes that a tumour may develop over the course of several years. In addition, certain factors can increase the risk of an HPV infection developing into cervical cancer. These include:
- smoking
- early onset of sexual activity
- frequent changes of sexual partners
- other sexually transmitted infections, such as HIV or chlamydia
- a pre-existing HPV infection
- a severely weakened immune system
- taking medicines that suppress the immune system (immunosuppressants)
Not all links between these risk factors and the development of cervical cancer are fully understood. One thing is certain, however: almost all cases of cervical cancer are caused by an HPV infection.
What types of HPV are there?
There are more than 200 different types of human papillomavirus (HPV). They are classified into low-risk and high-risk types depending on their risk of causing cell changes and cancer.
Low-risk types
These include, amongst others, HPV types 6, 11, 40, 42, 43 and 44. These viruses do not usually cause cancer. HPV 6 and HPV 11 are the most common causes of genital warts.
High-risk types
High-risk types can contribute to the development of cancer. They are associated not only with cervical cancer, but also with cancer of the vagina, vulva, anus and penis, as well as with certain types of cancer in the mouth and throat. The most important high-risk types include HPV 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66 and 68. Not all HPV types carry the same risk of causing cancer. In the case of cervical cancer, HPV 16 and HPV 18 in particular play a decisive role. Together, they are responsible for more than 70 per cent of all cases. Therefore, a positive HPV test does not automatically mean the same level of risk. The key factor is which type of HPV is causing the infection.
How do you become infected with HPV?
Human papillomaviruses (HPV) are primarily transmitted through sexual contact. This includes not only vaginal intercourse but also anal and oral sex. The viruses can be transmitted by both women and men. Infection is also possible through close skin-to-skin and mucous membrane contact in the genital area. In rare cases, the virus can be passed from mother to child during childbirth. Unlike other sexually transmitted viruses, such as HIV, an HPV infection does not require the exchange of bodily fluids. Even close skin-to-skin contact can be sufficient for transmission. HPV is predominantly transmitted through sexual contact. HPV infections are among the most common sexually transmitted viral diseases. Around four in five people become infected with HPV at some point in their lives. Most people affected do not notice the infection, as it usually causes no symptoms. Consequently, many people are unaware that they can pass the virus on. An HPV infection often clears up on its own. In some cases, however, the virus persists in the body. Depending on the type of HPV, this can then lead to genital warts or certain types of cancer. It is also possible to be infected with several types of HPV at the same time. Condoms reduce the risk of HPV transmission but do not offer complete protection, as HPV can also be transmitted through skin-to-skin contact in the genital area. 
How can cervical cancer be prevented?
Infection with a high-risk HPV type, such as HPV 16 or HPV 18, does not automatically lead to cervical cancer. In most cases, cell changes first occur in the cervix. These precancerous changes are known as cervical intraepithelial neoplasia (CIN) or dysplasia. In most cases, the immune system successfully clears the virus. However, if the infection persists for a long time, the cell changes may progress further. If left untreated, these can develop into precancerous lesions and eventually into cervical cancer. It usually takes several years for cervical cancer to develop. It is precisely this long development period that makes early detection so important. Regular screening tests make it possible to detect and treat cell changes at an early stage, before cancer develops.
Pap smear (cervical smear)
The PAP smear (cervical smear) is the most important test for the early detection of cervical cancer. During the procedure, the gynaecologist uses a small brush to collect cells from the surface of the cervix and from the cervical canal. The sample is then examined in the laboratory. The PAP smear enables cell changes and precancerous lesions to be detected at an early stage. This means that any precancerous lesions of cervical cancer can be treated in good time. However, the test does not show whether an HPV infection is present or which type of HPV can be detected. You can read more about the PAP smear here.
HPV test
An HPV test can determine whether HPV is present on the cervix. In particular, it screens for so-called high-risk HPV types, which are associated with the development of cervical cancer. Certain tests can also identify the specific HPV type involved. Whether an HPV test is carried out depends, amongst other things, on age, the recommendations of the relevant screening programme and individual test results. The sample is taken in a similar way to a PAP smear: cells or cellular material are collected from the cervix using a small brush and then examined in the laboratory. Whilst the Pap smear assesses changes in the cells, the HPV test detects an infection with human papillomavirus. You can read more about this here.
HPV vaccination
The most effective measure for preventing cervical cancer is the HPV vaccination. The 9-valent vaccine used in Austria protects against several HPV types, including the high-risk types HPV 16 and HPV 18, which are responsible for a large proportion of cervical cancer cases. The vaccine offers the best protection when administered before the first exposure to HPV. However, it can also be beneficial later on, as it can protect against HPV types with which the person has not yet been infected. You can read more about HPV vaccination here. 
What are the symptoms of cervical cancer?
Cervical cancer usually causes no symptoms in its early stages. Precancerous changes also tend to develop without being noticed. This is why regular gynaecological screening is important – even if there are no symptoms. The earlier cell changes are detected, the easier they are to treat and the better the chances of recovery. Possible signs of cervical cancer may include:
- unusual or foul-smelling vaginal discharge
- bleeding during or after sexual intercourse
- Intermenstrual bleeding
If the disease is already at a more advanced stage, the following symptoms, amongst others, may occur:
- Pain in the pelvic or sacral region
- Pain when passing urine
- Recurrent inflammation of the bladder or renal pelvis
- other symptoms, depending on the extent of the condition
The symptoms listed can have many different causes and do not automatically mean that cervical cancer is present. Conversely, not all of these symptoms occur in cases of cervical cancer. If you experience persistent, unusual or unexplained symptoms, or if you suspect you may have cervical cancer, you should always seek medical advice.
How is cervical cancer treated?
Various treatment options are available for cervical cancer. The recommended treatment depends primarily on the stage of the disease and the patient’s individual circumstances. The main treatment options include:
- Surgery
- Radiotherapy
- Chemotherapy
- Combined radiotherapy and chemotherapy (radiochemotherapy)
Surgical treatment
In the early stages, cervical cancer is usually treated with surgery. Depending on how far the tumour has spread, either parts of the cervix or the entire uterus are removed. In some cases, the surrounding pelvic connective tissue and lymph nodes are also removed. The extent of the operation depends on how far the cancer has spread.
Radiotherapy and chemotherapy
If the disease is more advanced or if certain risk factors are present, a combination of radiotherapy and chemotherapy (radiochemotherapy) is often recommended. In some cases, all three treatment methods – surgery, radiotherapy and chemotherapy – are used. Medicines may also be administered to alleviate symptoms and side effects of the treatment.
Treatment for advanced disease
If cervical cancer has already spread widely or can no longer be completely cured, the focus is often on managing the disease. The aim of treatment is to slow tumour growth for as long as possible, relieve symptoms and maintain quality of life. Individually tailored pain management and the treatment of other symptoms are important components of care.